Table 1 Clinicopathological features of 40 cases for discovery purpose
Sample no. | Group | Age | Gender | Virus infection status | Child-Pugh classification | Adjacent liver tissue | AFP (ng/ml) | TNM stagea | Tumor number | Tumor size (cm) | Differentiationb | Portal vein invesion | Intrahepatic metastasis | Duration of recurrence (year) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | S | 63 | M | None | A | CH | 137.5 | 3B | Single | 7.30 | Por | Presence | Presence | 0.53 |
2 | S | 27 | M | HBV | A | CH | 91,850 | 2 | Multiple | 10.00 | Por | Presence | Absence | 0.63 |
3 | S | 72 | M | None | A | CH | 8061 | 2 | Single | 8.50 | Por | Presence | Absence | 0.89 |
4 | S | 29 | F | HBV | A | Normal | 56,570 | 2 | Single | 14.50 | Por | Presence | Absence | 1.84 |
5 | S | 70 | M | HBV | A | CH | 965.9 | 2 | Multiple | 3.30 | Por | Presence | Absence | 0.52 |
6 | S | 52 | F | HBV | B | CH | 57,820 | 3B | Single | 11.00 | Por | Presence | Presence | 0.18 |
7 | S | 44 | M | HBV | A | CH | 2664 | 2 | Single | 4.50 | Por | Presence | Presence | 0.71 |
8 | S | 72 | M | None | A | CH | 107,890 | 2 | Single | 10.00 | Por | Presence | Presence | 0.27 |
9 | S | 68 | M | HBV | A | CH | 4739 | 2 | Single | 12.50 | Por | Presence | Presence | 0.19 |
10 | S | 52 | M | HBV | A | CH | 526 | 2 | Single | 7.30 | Mod | Presence | Presence | 0.50 |
11 | L | 71 | M | None | A | CH | 4.5 | 1 | Single | 3.50 | Mod | Absence | Absence | 3.33 |
12 | L | 51 | M | HBV | A | CH | 18.5 | 1 | Single | 12.00 | Mod | Absence | Absence | 3.07 |
13 | L | 62 | M | None | A | CH | 18.8 | 1 | Single | 2.80 | Mod | Absence | Absence | 4.96 |
14 | L | 73 | M | HBV | A | CH | 4.9 | 1 | Single | 4.50 | Mod | Absence | Absence | 2.99 |
15 | L | 64 | M | HCV | A | CH | 3.1 | 1 | Multiple | 2.10 | Mod | Absence | Absence | 7.08 |
16 | L | 72 | M | HCV | A | LC | 102.3 | 1 | Multiple | 3.00 | Well | Absence | Absence | 5.74 |
17 | L | 52 | F | HBV | A | CH | 12.2 | 1 | Single | 2.00 | Mod | Absence | Absence | 2.38 |
18 | L | 62 | M | HCV | B | CH | 5.5 | 1 | Single | 2.50 | Mod | Absence | Absence | 3.38 |
19 | L | 71 | M | None | A | CH | 3.2 | 1 | Single | 2.00 | Mod | Absence | Absence | 4.89 |
20 | L | 65 | M | HCV | B | LC | 34.1 | 1 | Single | 3.40 | Mod | Absence | Absence | 2.85 |
21 | A | 70 | M | HCV | – | CH | – | – | – | – | – | – | – | – |
22 | A | 79 | M | HCV | – | CH | – | – | – | – | – | – | – | – |
23 | A | 36 | M | HBV | – | CH | – | – | – | – | – | – | – | – |
24 | A | 57 | M | HBV | – | LC | – | – | – | – | – | – | – | – |
25 | A | 51 | M | HBV | – | CH | – | – | – | – | – | – | – | – |
26 | A | 53 | M | None | – | LC | – | – | – | – | – | – | – | – |
27 | A | 63 | F | HCV | – | CH | – | – | – | – | – | – | – | – |
28 | A | 61 | M | HBV | – | LC | – | – | – | – | – | – | – | – |
29 | A | 72 | M | HCV | – | LC | – | – | – | – | – | – | – | – |
30 | A | 52 | F | HBV | – | CH | – | – | – | – | – | – | – | – |
31 | N | 58 | F | None | – | Normal | – | – | – | – | – | – | – | – |
32 | N | 49 | M | None | – | Normal | – | – | – | – | – | – | – | – |
33 | N | 74 | M | None | – | Normal | – | – | – | – | – | – | – | – |
34 | N | 39 | M | None | – | Normal | – | – | – | – | – | – | – | – |
35 | N | 68 | M | None | – | Normal | – | – | – | – | – | – | – | – |
36 | N | 64 | M | None | – | Normal | – | – | – | – | – | – | – | – |
37 | N | 32 | M | None | – | Normal | – | – | – | – | – | – | – | – |
38 | N | 70 | F | None | – | Normal | – | – | – | – | – | – | – | – |
39 | N | 61 | M | None | – | Normal | – | – | – | – | – | – | – | – |
40 | N | 59 | M | None | – | Normal | – | – | – | – | – | – | – | – |